Intra-artery infusion of recombinant human erythropoietin reduces blood–brain barrier disruption in rats following cerebral ischemia and reperfusion
Rongliang Wang(Ministry of Education of the People's Republic of China), Haiping Zhao(Qingdao Agricultural University), Jia Liang(The People's Hospital of Guangxi Zhuang Autonomous Region), Zhifeng Qi(Ministry of Education of the People's Republic of China), Xiangrong Liu(Hunan University), Xiaoning Wu(First Affiliated Hospital of Xi'an Jiaotong University), Lianqiu Min(Jinzhou Medical University), Yumin Luo(Chemnitz University of Technology), Xunming Ji(Capital Medical University)
Cited by 29
Related Papers
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
|Hepatology|2016|156
CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1
|Current Biology|1996|138
Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019
|BMC Public Health|2024|123
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
|Clinical Gastroenterology and Hepatology|2020|115